Michael Grusch

Michael Grusch is an Associate Professor and Group Leader at the Medical University of Vienna's Center for Cancer Research, specializing in Applied and Experimental Oncology. His research focuses on understanding how growth factors regulate cancer cell growth, migration, invasion, and drug response, with particular emphasis on fibroblast growth factors (FGF), epidermal growth factor (EGF), activins, and Y-box binding protein 1 (YB-1) in pleural mesothelioma and lung cancer.

Dr. Grusch's research interests center on molecular mechanisms driving cancer progression. His work investigates how growth factor signaling pathways contribute to malignancy and how this knowledge can be translated into therapeutic interventions. His laboratory employs advanced techniques including optogenetics to precisely control and study receptor tyrosine kinases in cancer cells.

Analysis of his recent publications reveals consistent focus on growth factor signaling in cancer, particularly in mesothelioma and lung cancer. His work spans basic molecular mechanisms to potential therapeutic applications, with notable contributions in fibroblast growth factor research, epithelial-mesenchymal transition, and the development of optogenetic tools for cancer research. His publications show a strong interdisciplinary approach combining molecular biology, cell signaling, and innovative technological applications.

Dr. Grusch has made significant contributions to understanding fibroblast growth factor receptor expression in pleural mesothelioma and its relationship to patient survival and treatment response. His work on activin A has positioned it as a potential target for improving cancer treatment.

His research program demonstrates a consistent trajectory of investigating growth factor signaling pathways in cancer biology, with applications spanning basic science to potential therapeutic interventions. He maintains an active publication record with contributions to high-impact journals in oncology and molecular biology.